A Study on the Immunogenicity and Safety of 3 Different Dose Concentrations of a Respiratory Syncytial Virus Vaccine in Infants and Toddlers

NCT06705140 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

947

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor decision

Conditions

RSV Immunisation

Interventions

BIOLOGICAL: Low Dose (LD) RSVt vaccine
BIOLOGICAL: Standard Dose (SD) RSVt vaccine
BIOLOGICAL: High Dose (HD) RSVt vaccine
BIOLOGICAL: Placebo

Sponsor

Sanofi Pasteur, a Sanofi Company